The short version of GHRH receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-20. Anything still debated is marked as such rather than presented as settled.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (with DAC) | ~3647 Da | Calculated from the full amino acid sequence |
| Molecular weight (without DAC) | ~3368 Da | Mod GRF(1-29) variant |
| Appearance | White lyophilized powder | Typical form supplied for research |
| Solubility | Soluble in water | Dissolves in aqueous buffers |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
=== Customer base === Outside of the Philippines, Jollibee's customer base varies by region. In the Middle East, Jollibee's primary market are overseas Filipino workers, while in Vietnam it is the local population. Vietnam has the most franchises outside of the Philippines, with over 100 locations.
Each new scientific advance became a media event designed to capture public support, and by the 1980s, biotechnology grew into a promising real industry. In 1988, only five proteins from genetically engineered cells had been approved as drugs by the United States Food and Drug Administration (FDA), but this number would skyrocket to over 125 by the end of the 1990s. The field of genetic engineering remains a heated topic of discussion in today's society with the advent of gene therapy, stem cell research, cloning, and genetically modified food. While it seems only natural nowadays to link pharmaceutical drugs as solutions to health and societal problems, this relationship of biotechnology serving social needs began centuries ago.
=== Scientific === Radon emanation from the soil varies with soil type and with surface uranium content, so outdoor radon concentrations can be used to track air masses to a limited degree. Because of radon's rapid loss to air and comparatively rapid decay, radon is used in hydrologic research that studies the interaction between groundwater and streams. Any significant concentration of radon in a river may be an indicator that there are local inputs of groundwater. Radon soil concentration has been used to map buried close-subsurface geological faults because concentrations are generally higher over the faults. Similarly, it has found some limited use in prospecting for geothermal gradients. Some researchers have investigated changes in groundwater radon concentrations for earthquake prediction. Increases in radon were noted before the 1966 Tashkent and 1994 Mindoro earthquakes. Radon has a half-life of approximately 3.8 days, which means that it can be found only shortly after it has been produced in the radioactive decay chain. For this reason, it has been hypothesized that increases in radon concentration is due to the generation of new cracks underground, which would allow increased groundwater circulation, flushing out radon. The generation of new cracks might not unreasonably be assumed to precede major earthquakes. In the 1970s and 1980s, scientific measurements of radon emissions near faults found that earthquakes often occurred with no radon signal, and radon was often detected with no earthquake to follow.
=== Laminar flow reactor === In a laminar flow reactor, the fluid flows through a long tube or parallel plate reactor and the flow is in layers parallel to the walls of the tube. The velocity of the flow is a parabolic function of radius. In the absence of molecular diffusion, the RTD is
Steiner believed that nationalism is too inherently violent to satisfy the moral prerogative of Judaism, having said "that because of what we are, there are things we can't do " and has suggested that Nazism was Europe's revenge on the Jews for inventing conscience; father of David Steiner (academic); executive director of the Johns Hopkins Institute for Education Policy; appointed to the Practitioner Council at the Hoover Institute, Stanford University. Hillel Steiner (born 1942) is a prolific author, scholar, academic, editor and political philosopher and is Emeritus Professor of Political Philosophy at the University of Manchester; signatory to the Euston Manifesto and elected to the Fellowship of the British Academy in 1999. He is a member of the following organisations: American Philosophical Association, Aristotelian Society, International Association for the Philosophy of Law and Social Philosophy, Basic Income Earth Network. British Philosophical Association, European Society for the History of Economic Thought, Political Studies Association, Society for Applied Philosophy, and the September Group.
Sources: en.wikipedia.org
=== University of Nebraska Medical Center === Markin was awarded the Ida Ittner Postdoctoral Fellowship studying lead toxicity in children from 1980 to 1982, working in the laboratory of Dr. Carol R. Angle. In 2005, Markin was named the David T. Purtilo Professor of Pathology and Microbiology. Markin helped develop Children's Specialty Physicians, the pediatric practice plan for the UNMC College of Medicine at Children's Hospital & Medical Center. Markin also holds appointments in the Departments of Surgery and Psychiatry. Markin was inducted into the National Academy of Inventors Fellows Class of 2015. He has also received the Lifetime Achievement Award from UNeMed Corporation, UNMC's technology transfer office, for his innovations that have transformed the clinical laboratory. Markin leads the telehealth initiative of UNMC and Nebraska Medicine. Since 2011, he has served as associate vice chancellor for business development and as chief technology officer. In October 2005, the U.S. Defense Department provided a grant to Markin and his team to design a new method for microbiology automation. Known as the Microbiology Automation Research Project, or "MARP," the project is designed to develop a broad platform that can be used in the clinical laboratory, including applications for bacteriology, mycology and virology. Additionally, the project has potential uses for other applications, including bioterrorism testing, and holds significant promise for the civilian sector. Markin holds several patents, and has written numerous industry articles on laboratory automation.
Bis(2-sulfanylethyl)amido group, also called SEA group, belongs to this family. Polypeptide C-terminal bis(2-sulfanylethyl)amides (SEA peptide segments) react with Cys peptide to give a native peptide bond as in NCL. This reaction, which is called SEA Native Peptide Ligation, is a useful variant of native chemical ligation. In making peptide segments that contain an N-terminal cysteine residue, exposure to ketones should be avoided since these may cap the N-terminal cysteine. Do not use protecting groups that release aldehydes or ketones. For the same reason, the use of acetone should be avoided, particularly in washing glassware used for lyophilization. A feature of the native chemical ligation technique is that the product polypeptide chain contains cysteine at the site of ligation. The cysteine at the ligation site can be desulfurized to alanine, thus extending the range of possible ligation sites to include alanine residues. Other beta-thiol containing amino acids can be used for native chemical ligation, followed by desulfurization. Alternatively, thiol-containing ligation auxiliaries can be used that mimic an N-terminal cysteine for the ligation reaction, but which can be removed after synthesis. The use of thiol-containing auxiliaries may not be as effective as ligation at a Cys residue. Native chemical ligation can also be performed with an N-terminal selenocysteine residue.
=== Mechanism of elastic recoil === The characterization of disorder is consistent with an entropy-driven mechanism of elastic recoil. It is concluded that conformational disorder is a constitutive feature of elastin structure and function.
At least one more regulated transport process is involved. The stoichiometry of bone mineral basically is that of hydroxyapatite precipitating from phosphate, calcium, and water at a slightly alkaline pH:
==== Chalcogenides and pnictides ==== Indium derivatives of chalcogenides (O, S, Se, Te) are well developed. Indium(III) oxide, In2O3, forms when indium metal is burned in air or when the hydroxide or nitrate is heated. The analogous sesqui-chalcogenides with sulfur, selenium, and tellurium are also known. The chemistry of indium pnictides (N, P, As, Sb) is also well known, motivated by their relevance to semiconductor technology. For applications in microelectronics, the P, As, and Sb derivatives are made by reactions of trimethylindium:
Sources: en.wikipedia.org
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.
The maleimide group forms a covalent link with albumin, an abundant blood protein. This attachment slows clearance, so a single administration persists much longer than the unmodified peptide. The feature is the main reason the two variants are handled differently in study design.
It is not an approved therapeutic product in major regulatory jurisdictions. It appears in research chemical catalogs and scientific literature rather than pharmacy shelves. Clinical development was limited and did not reach approval.
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.